Identification of a novel DEC-205 binding peptide to develop dendritic cell-targeting nanovaccine for cancer immunotherapy.
Zheng J, Wang M, Pang L, Wang S, Kong Y, Zhu X, Zhou X, Wang X, Chen C, Ning H, Zhao W, Zhai W, Qi Y, Wu Y, Gao Y.
Zheng J, et al. Among authors: wang x, wang m, wang s.
J Control Release. 2024 Sep;373:568-582. doi: 10.1016/j.jconrel.2024.07.056. Epub 2024 Jul 30.
J Control Release. 2024.
PMID: 39067792